{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:55:16Z","timestamp":1781513716803,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82172809"],"award-info":[{"award-number":["No. 82172809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00210-026-05096-0","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T04:27:49Z","timestamp":1772684869000},"page":"12141-12155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Citronellol potentiates sunitinib efficacy in renal cell carcinoma by targeting JAK2\/STAT3 signaling pathway"],"prefix":"10.1007","volume":"399","author":[{"given":"Zongrun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"5096_CR1","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.ejca.2015.08.017","volume":"51","author":"L Albiges","year":"2015","unstructured":"Albiges L, Fay AP, Xie W, Krajewski K, McDermott DF, Heng DYC, Dariane C, DeVelasco G, Lester R, Escudier B (2015) Efficacy of targeted therapies after PD-1\/PD-L1 blockade in metastatic renal cell carcinoma. Eur J Cancer 51:2580\u20132586","journal-title":"Eur J Cancer"},{"key":"5096_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"5096_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106556","volume":"123","author":"Z Chen","year":"2024","unstructured":"Chen Z, Cheng S, Xu An, Han C, Jia X, Liu M (2024a) Syringin as a novel therapeutic agent for renal cell carcinoma by targeting EGFR\/PI3K\/Akt pathway and enhancing sunitinib efficacy. J Funct Foods 123:106556","journal-title":"J Funct Foods"},{"key":"5096_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biom14081043","volume":"14","author":"Z Chen","year":"2024","unstructured":"Chen Z, Wang C, Cai Y, Xu An, Han C, Tong Y, Cheng S, Liu M (2024b) Revealing the mechanism of Esculin in treating renal cell carcinoma based on network pharmacology and experimental validation. Biomolecules 14:1043","journal-title":"Biomolecules"},{"key":"5096_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102528","volume":"115","author":"C Ciccarese","year":"2023","unstructured":"Ciccarese C, Strusi A, Arduini D, Russo P, Palermo G, Foschi N, Racioppi M, Tortora G, Iacovelli R (2023) Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario. Cancer Treat Rev 115:102528","journal-title":"Cancer Treat Rev"},{"key":"5096_CR6","doi-asserted-by":"publisher","first-page":"101938","DOI":"10.1016\/j.mcp.2023.101938","volume":"72","author":"H Deng","year":"2023","unstructured":"Deng H, Gong X, Ji G, Li C, Cheng S (2023) KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2\/STAT3 signaling pathway. Mol Cell Probes 72:101938","journal-title":"Mol Cell Probes"},{"key":"5096_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/0008-5472.CAN-16-3088","volume":"77","author":"M Dufies","year":"2017","unstructured":"Dufies M, Giuliano S, Ambrosetti D, Claren A, Ndiaye PD, Mastri M, Moghrabi W, Cooley LS, Ettaiche M, Chamorey E (2017) Sunitinib stimulates expression of VEGFC by tumor cells and promotes lymphangiogenesis in clear cell renal cell carcinomas. Cancer Res 77:1212\u20131226","journal-title":"Cancer Res"},{"key":"5096_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Gr\u00fcnwald V, Gillessen S, Horwich A, ESMO Guidelines Committee (2019) Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 30:706\u2013720","journal-title":"Ann Oncol"},{"key":"5096_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100929","volume":"67","author":"J Jin","year":"2023","unstructured":"Jin J, Xie Y, Zhang J-S, Wang J-Q, Dai S-J, He W-F, Li S-Y, Ashby CR Jr, Chen Z-S, He Q (2023) Sunitinib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers. Drug Resist Updat 67:100929","journal-title":"Drug Resist Updat"},{"key":"5096_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbcan.2016.03.005","volume":"1865","author":"VS Jones","year":"2016","unstructured":"Jones VS, Huang R-Y, Chen L-P, Chen Z-S, Fu L, Huang R-P (2016) Cytokines in cancer drug resistance: cues to new therapeutic strategies. Biochimica Et Biophysica Acta (BBA)-Rev on Cancer 1865:255\u2013265","journal-title":"Biochimica Et Biophysica Acta (BBA)-Rev on Cancer"},{"key":"5096_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166941","volume":"1870","author":"ZR Kang","year":"2024","unstructured":"Kang ZR, Jiang S, Han JX, Gao Y, Xie Y, Chen J, Liu Q, Yu J, Zhao X, Hong J, Chen H, Chen YX, Chen H, Fang JY (2024) Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development. Biochim Biophys Acta Mol Basis Dis 1870:166941","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5096_CR12","doi-asserted-by":"publisher","first-page":"167250","DOI":"10.1016\/j.bbadis.2024.167250","volume":"1870","author":"SJ Lee","year":"2024","unstructured":"Lee SJ, Jeon SH, Cho S, Kim CM, Yoo JK, Oh SH, Kim JH, Yang YD, Kim JK (2024) hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cells. Biochimica Et Biophysica Acta (BBA) 1870:167250","journal-title":"Biochimica Et Biophysica Acta (BBA)"},{"key":"5096_CR13","doi-asserted-by":"crossref","unstructured":"Lee H, Pal SK, Reckamp K, Figlin RA, Yu H (2010) STAT3: a target to enhance antitumor immune response. Cancer Immunol Immunother 41\u201359","DOI":"10.1007\/82_2010_51"},{"key":"5096_CR14","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/1538-7445.AM2018-2162","volume":"78","author":"Ru Li","year":"2018","unstructured":"Li Ru, Huang Y, Liu H, Dilger JP, Lin J (2018) Abstract 2162: comparing volatile and intravenous anesthetics in a mouse model of breast cancer metastasis. Cancer Res 78:2162\u20132262","journal-title":"Cancer Res"},{"key":"5096_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154069","volume":"238","author":"Y Liu","year":"2022","unstructured":"Liu Y, Xing Z, Yuan M, Xu B, Chen L, Zhang D, Zhou Y, Huang H, Zheng X, Zhang J (2022) IL1R2 promotes tumor progression via JAK2\/STAT3 pathway in human clear cell renal cell carcinoma. Pathol Res Pract 238:154069","journal-title":"Pathol Res Pract"},{"key":"5096_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1124\/jpet.115.226639","volume":"355","author":"A Mizumoto","year":"2015","unstructured":"Mizumoto A, Yamamoto K, Nakayama Y, Takara K, Nakagawa T, Hirano T, Hirai M (2015) Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines. J Pharmacol Exp Ther 355:152\u2013158","journal-title":"J Pharmacol Exp Ther"},{"key":"5096_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1416794","volume":"15","author":"L Ou","year":"2024","unstructured":"Ou L, Hao Y, Liu H, Zhu Z, Li Q, Chen Q, Wei R, Feng Z, Zhang G, Yao M (2024) Chebulinic acid isolated from aqueous extracts of Terminalia chebula Retz inhibits Helicobacter pylori infection by potential binding to Cag A protein and regulating adhesion. Front Microbiol 15:1416794","journal-title":"Front Microbiol"},{"key":"5096_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13192-8","volume":"24","author":"R Pacholczak-Madej","year":"2024","unstructured":"Pacholczak-Madej R, Drobniak A, Stok\u0142osa \u0141, Bidas A, Dobrza\u0144ska J, Grela-Wojewoda A, Roman A, Tusie\u0144-Ma\u0142ecka D, Walocha J, Blecharz P (2024) Adverse events after nivolumab and ipilimumab combined immunotherapy in advanced renal cell carcinoma: a multicentre experience in Poland. BMC Cancer 24:1411","journal-title":"BMC Cancer"},{"key":"5096_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05717-z","volume":"14","author":"Yi Shou","year":"2023","unstructured":"Shou Yi, Yue C, Wang Qi, Liu J, Xu J, Miao Qi, Liu Di, Yang H, Liu Y, Zhang X (2023) circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM\/IL-6\/STAT3 pathway. Cell Death Dis 14:232","journal-title":"Cell Death Dis"},{"key":"5096_CR20","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349","journal-title":"CA Cancer J Clin"},{"key":"5096_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA (2024) Cancer treatments: past, present, and future. Cancer Genet 286\u2013287:18\u201324","journal-title":"Cancer Genet"},{"key":"5096_CR22","doi-asserted-by":"crossref","unstructured":"Uchendu IK, Tchawe YSN, Zhilenkova AV, Sangadzhieva ZD, Rusanov AS, Bagmet LN (2023) Epidemiology patterns of renal cell carcinoma worldwide: examining risk factors and contemporary immunotherapy approaches","DOI":"10.20944\/preprints202310.1757.v1"},{"key":"5096_CR23","first-page":"878","volume":"15","author":"J Wang","year":"2023","unstructured":"Wang J, Ju H-J, Zhang F, Tian H, Wang W-G, Ma Y-L, Xu W-S, Wang Y-H (2023) A novel NSUN5\/ENO3 pathway promotes the Warburg effect and cell growth in clear cell renal cell carcinoma by 5-methylcytosine-stabilized ENO3 mRNA. Am J Transl Res 15:878","journal-title":"Am J Transl Res"},{"key":"5096_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s11658-022-00337-5","volume":"27","author":"C Xiao","year":"2022","unstructured":"Xiao C, Zhang W, Hua M, Chen H, Yang B, Wang Ye, Yang Q (2022) RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1\/JAK\/STAT3 feedback loop. Cell Mol Biol Lett 27:36","journal-title":"Cell Mol Biol Lett"},{"key":"5096_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-01018-5","volume":"19","author":"Z Xu","year":"2024","unstructured":"Xu Z, Meegol Rasteh A, Dong A, Wang P, Liu H (2024) Identification of molecular targets of Hypericum perforatum in blood for major depressive disorder: a machine-learning pharmacological study. Chin Med 19:141","journal-title":"Chin Med"},{"key":"5096_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154182","volume":"102","author":"R Yu","year":"2022","unstructured":"Yu R, Zhou Y, Shi S, Wang X, Huang S, Ren Yu (2022) Icariside II induces ferroptosis in renal cell carcinoma cells by regulating the miR-324-3p\/GPX4 axis. Phytomedicine 102:154182","journal-title":"Phytomedicine"},{"key":"5096_CR27","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1002\/ptr.8295","volume":"38","author":"ZH Zhang","year":"2024","unstructured":"Zhang ZH, Yuan CY, Xu M, Wang MF, Feng T, Wang Y, Zheng SF, Zhang HL, Shi GH, Cao DL, Wang ZL, Ye DW (2024) Calycosin inhibits the proliferation and metastasis of renal cell carcinoma through the MAZ\/HAS2 signaling pathway. Phytother Res 38:4774\u20134791","journal-title":"Phytother Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05096-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:21:56Z","timestamp":1781511716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05096-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5096"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05096-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}